Back
ESSA Pharma Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Buy
71
EPIX
ESSA Pharma
Last Price:
6.81
Seasonality Move:
-21.1%
Sell
50
AUPH
Aurinia Pharmaceuticals
Last Price:
5.13
Seasonality Move:
3.33%
Buy
71
ESSA Pharma (EPIX)
is a Buy
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $6.70. The Score for EPIX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- EPIX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.12. The Score for AUPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $6.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing slight selling pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.12
The current trend is relatively stagnant and AUPH is experiencing slight selling pressure.
EPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 41.51 | Sell |
| Chaikin Money Flow: | -2339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.37 - 7.85) | Sell |
| Bollinger Bands (100): | (6.77 - 9.31) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | -28648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.94 - 5.14) | Buy |
| Bollinger Bands (100): | (5 - 8.22) | Sell |
EPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.6 | Buy |
| 20-day SMA: | 6.86 | Sell |
| 50-day SMA: | 8.03 | Sell |
| 200-day SMA: | 5.89 | Buy |
| 8-day EMA: | 6.72 | Sell |
| 20-day EMA: | 6.96 | Sell |
| 50-day EMA: | 7.56 | Sell |
| 200-day EMA: | 6.45 | Buy |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.09 | Buy |
| 20-day SMA: | 5.04 | Buy |
| 50-day SMA: | 5.18 | Sell |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 5.1 | Buy |
| 20-day EMA: | 5.09 | Buy |
| 50-day EMA: | 5.45 | Sell |
| 200-day EMA: | 7.22 | Sell |
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.32 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
ESSA Pharma Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||